CDH2 and carcinoma: N-cadherin is normally absent or expressed at low levels in normal epithelial cells; altered expression of N-cadherin in epithelial tumor cells is a well-documented feature of malignant epithelial neoplasms such as breast, prostate, urothelial and pancreatic cancer, and is associated with disease progression.